ArticleJournal of thoracic disease2026
Optimal drug regimens for squamous non-small cell lung cancer: a systematic review and a Bayesian network meta-analysis of randomized trials.
Yan Ye et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.